Menu

Amneal Pharmaceuticals, Inc. AMRX

Full chart Compare
Set alert

Price alert · AMRX

All alert types
21.28 USD +1.14 (+5.66%)

At closeNov 9, 2026, 7:28 PM EST

21.54 +0.26 +1.21%

After hours · Nov 9, 7:28 PM ET

20.29 Day range 21.37
11.37 52-week range 21.51
YTD
+68.89%
1 year
+87.16%

Discussion (23)

Sign in to join the discussion

vitamin guy AMRX 5 years ago #11

Garbage company, way too much debt, with no way of paying it off. Much better generic companies. Check out LCI, great future, and debt under control.

vitamin guy AMRX 5 years ago #12

Three billion in debt, and no plan on how to reduce it. One hiccup, and lights out

vitamin guy AMRX 5 years ago #13

Much better generic drug play is LCI. They’re doing everything right. All debt refinanced and no longer an issue. Advair launch next year, should add at least 500 million in sales. The following year should see the launch of generic insulin, with possible sales of 1 billion. Following year should be the launch of another insulin product and another bronchial product with an additional billion in sales. Five year plan, no debt, and over 2.5 billion in sales. AMRX is dead in the water, with no plan to service their multi billion in debt.

vitamin guy AMRX 5 years ago #14

These guys need to stop spending, and start dealing with their debt. Over 3 billion in debt, and they keep spending. They are digging their hole to deep, to ever be able to get out.

vitamin guy AMRX 5 years ago #15

I’m out!!! This stock just can’t make anything happen. Three billion in debt, and they keep spending, they need to pay this down. They completely screwed up the Jerome Stevens ( Levothyroxine) deal. They probably paid well over 200 million for a crap item. They should have let Lannett keep the item. Looks like Lannett was the smart one there. These guys can’t do anything right!! Good luck

vitamin guy AMRX 5 years ago #16

The problem with this company, is they keep spending money they don’t have. Three billion in debt, and they’re buying companies. They need to concentrate on reducing debt. This is a bankruptcy waiting to happen!!

vitamin guy AMRX 6 years ago #17

Even if sales pick way up, it’s not a high profit item, and they obviously can’t raise the price, as well as mylan & teva giving it to the government. Don’t see a huge play here, especially remdesivir is actually showing some really positive results. This could be a good company to invest in , but I’d be careful. ——————————————————-

vitamin guy AMRX 6 years ago #18

Africa is just behind other countries, it’s starting now, and will probably be one of the hardest hit, since they lack in hospitals and medical equipment!! I hope it’s any one of these drug companies that get it. We need something, and we need it fast, but I’m not hanging my hat on trump getting behind this drug. He may know something, but the fda isn’t agreeing with him on this one. Let’s wait, see and hope!! There’s a few hats in the ring. Three or four drugs that they are working on, just hope it’s one of them!!!————

vitamin guy AMRX 6 years ago #19

I’ve heard of so many side effects from this combination. It’s so confusing, Trump is all over this drug, when the UK won’t let the brand Kaletra be exported any longer because it’s showing so much promise. The Israeli government is breaking the patent on Kaletra because it shows so much promise, and the USA is get behind this malaria drug from 1944 with tons of horrible side effects. LCI is the only maker of the generic Kaletra, if it’s the drug that cured this mess, that company is gonna run. This drug has several competitors, and Mylan & Teva are giving it to the government. ——-/////——/////———————/

vitamin guy AMRX 6 years ago #20

Better play is LCI, they have the only genetic Kaletra, and the brand is not allowed to ship outside of the UK because such a high demand there. If it is Kaletra that is determined to be the best cure, LCI has it. Lots of testing going on with it, and it shows great promise. I’d rather put my money there on a chance of a profitable product, than here on a product with lots of competition and little profit. ————-/////——-